In vitro properties of a high affinity selective antagonist of the VIP1 receptor

Peptides

Volumn 18, Issue 10, 1997, Pages 1555-1560

  Gourlet, Philippe ^a   De Neef, Philippe ^a   Cnudde, Johnny ^a   Waelbroeck, Magali ^a   Robberecht, Patrick ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

VIP antagonists; VIP receptors

Indexed keywords

ADENYLATE CYCLASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL MEMBRANE; CHO CELL; ENZYME ACTIVITY; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR POTENTIAL;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CRICETINAE; HUMANS; IODINE RADIOISOTOPES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; RATS; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031427346     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00230-1     Document Type: Article

References (37)

1. Chakder S., Rattan S. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor functional and binding studies on opossum internal anal sphincter smooth muscle . J. Pharmacol. Exp. Ther. 266:1993;392-399.
2. Ciccarelli E., Vilardaga J. P., De Neef P., Di Paolo E., Waelbroeck M., Bollen A., Robberecht P. Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regul. Pept. 54:1994;397-407.
3. Ciccarelli E., Svoboda M., De Neef P., Di Paolo E., Bollen A., Dubeaux C., Vilardaga J.-P., Waelbroeck M., Robberecht P. Pharmacological properties of two recombinant splice variants of the PACAP type I receptor transfected and stably expressed in CHO cells. Eur. J. Pharmacol. 288:1995;259-267.
4. Couvineau A., Rouyer-Fessard C., Darmoul D., Maoret J. J., Carrero I., Ogier-Denis E., Laburthe M. Human intestinal VIP receptor Cloning and functional expression of two cDNA encoding proteins with different N-terminal domains . Biochem. Biophys. Res. Commun. 200:1994;769-776.
5. Couvineau A., Rouyer-Fessard C., Fournier A., St-Pierre S., Pipkorn R., Laburthe M. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes Effect of nine partial sequences . Biochem. Biophys. Res. Commun. 121:1984;493-498.
6. 1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide. J. Biol. Chem. 271:1996;12795-12800.
7. Fahrenkrug J. Vasoactive intestinal polypeptide measurement, distribution and putative neurotransmitter function . Digestion. 19:1979;149-169.
8. Fishbein V. A., Coy D. H., Hocart S. J., Jiang N. Y., Mrozinski J. E. Jr, Mantey S. A., Jensen R. T. A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists. Peptides. 15:1994;95-100.
9. Goossens J.-F., Pommery N., Lohez M., Pommery J., Helbecque N., Cotelle P., Lhermitte M., Henichart J.P. Antagonistic effect of vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea-pig trachea smooth muscle relaxation. Mol. Pharmacol. 41:1992;104-109.
10. 2 receptor subclass. Peptides. 18:1997;403-408.
11. 1 Receptor Agonists. Peptides (accompanying paper).
12. Gozes I., McCune S. K., Jacobson L., Warren D., Moody T. W., Fridkin M., Brenneman D. E. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257:1991;959-966.
13. Gozes I., Lilling G., Glazer R., Ticher A., Ashkenazi I. E., Davidson A., Rubinraut S., Fridkin M., Brenneman D. E. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J. Pharmacol. Exp. Ther. 273:1995;161-167.
14. Gozes Y., Brenneman D. E., Fridkin M., Asofsky R., Gozes I. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes. Brain Res. 540:1991;319-321.
15. Inagaki N., Yoshida H., Mizuta M., Mizuno N., Fujii Y., Gonoi T., Miyazaki J. I., Seino S. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. USA. 91:1994;2679-2683.
16. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
17. Krempels K., Usdin T. B., Harta G., Mezey E. PACAP acts through VIP type 2 receptors in the rat testis. Neuropeptides. 29:1995;315-320.
18. 1 hGRF is a competitive VIP antagonist in the rat . Mol. Pharmacol. 29:1986;23-27.
19. Laburthe M., Amiranoff B., Boige N., Rouyer-Fessard C., Tatemoto K., Moroder L. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin. FEBS Lett. 159:1983;89-92.
20. Laburthe M., Couvineau A., Rouyer-Fessard C., Moroder L. Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium comparison with rat intestinal receptors . Life Sci. 36:1985;991-995.
21. Leroux F., Goossens J.-F., Pommery N., Hénichart J.-P. A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells. Regul. Pept. 52:1994;119-128.
22. Lilling G., Wollman Y., Goldstein M. N., Rubinraut S., Fridkin M. Brenneman, D . E.; Gozes, I. Inhibition of human neuroblastoma growth by a specific VIP antagonist. J. Mol. Neurosci. 5:1994-1995;231-239.
23. 2 receptor molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide . FEBS Lett. 334:1993;3-8.
24. Moody T. W., Zia F., Draoui M., Brenneman D. E., Fridkin M., Davidson A., Gozes I. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. Proc. Natl. Acad. Sci. USA. 90:1993;4345-4349.
25. 17]VIP. Am. J. Physiol. 250:1986;G553-G557.
26. Robberecht P., Gourlet P., Vertongen P., Svoboda M. Characterization of the VIP receptor from SUP T1 lymphoblasts Advan. Neuroimmunol. 6:1996;49-57.
27. Robberecht P., Gourlet P., De Neef P., Woussen-Colle M.-C., Vandermeers-Piret M.-C., Vandermeers A., Christophe J. Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of Pituitary Adenylate Cyclase-Activating Peptides amino-terminally shortened or modified at position 1,2,3,20, or 21, Mol. Pharmacol. 42:1992;347-355.
28. Robberecht P., De Neef P., Gourlet P., Cauvin A., Coy D. H., Christophe J. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes. Regul. Pept. 26:1989;117-126.
29. Rorstad O. P., Wanke I., Coy D. H., Fournier A., Huang M. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. Mol. Pharmacol. 37:1990;971-1977.
30. 1 hGRF discriminates between VIP receptors from rat liver and intestinal epithelium. Life Sci. 45:1989;829-833.
31. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:1974;541-548.
32. Svoboda M., Tastenoy M., Van Rampelbergh J., Goossens J.-F., De Neef P., Waelbroeck M., Robberecht P. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts, Biochem. Biophys. Res. Commun. 205:1994;1617-1624.
33. Turner J. T., Jones S. B., Bylund D. B. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT 29. Peptides. 7:1986;849-854.
34. Usdin T. B., Bonner T. I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology. 135:1994;2662-2680.
35. 2 receptor. Neuropeptides. 30:1996;491-496.
36. Vertongen, P.; Verslijpe, M.; Gourlet, P.; Schiffmann, S.; Vanderhaeghen. J.-J.; Robberecht, P. Autoradiographic visualization of the receptor subclasses for Vasoactive Intestinal Polypeptide (VIP) in rat brain. Peptides (accompanying paper).
37. 2 as a VIP antagonist. Endocrinology. 116:1985;2643-2649.